Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy

08.10.2018

Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use. With the help of this new cancer vaccine platform, the activation of the human immune response against cancer cells becomes significantly more effective.

"What is actually the most remarkable insight concerning the PeptiENV cancer vaccine platform is that we are able to envelop oncolytic viruses with the patient's own cancer peptides, enabling tailored targeted treatment," says Erkko Ylösmäki, an Academy of Finland post-doctoral researcher working in the ImmunoViroTherapy Lab of the Faculty of Pharmacy, University of Helsinki.


This is a cancer vaccine platform, which consists of silver colored enveloped viruses, onto which a patient's cancer peptides has been tied to (in white, green and pink).

Credit: Vincenzo Cerullo

Oncolytic viruses are naturally occurring viruses that have been modified to restrict their division into cancer cells only. Virotherapy is usually administered as an injection to the tumour or the abdominal cavity, or intravenously.

A virus enveloped with peptides through the PeptiENV platform can effectively "train" the patient's own, locally active T cells to identify tumour cells. Thus, the amount of T cells able to identify tumour cells increases in the cancerous tissue, improving the efficacy of the cancer therapy.

The study demonstrated the functionality of the PeptiENV cancer vaccine platform in conjunction with oncolytic enveloped herpes simplex virus 1, already used in the treatment of metastatic melanoma. Oncolytic vaccinia viruses, among others currently under investigation in clinical trials, are also compatible with the cancer vaccine platform.

Additionally, the number of T cells in the cancerous tissue that are able to identify cancer cells strongly correlates with the therapeutic effect of new immune checkpoint inhibitors.

"We aim to expand the pool of patients that could potentially benefit from the unparalleled efficacy of immune checkpoint inhibitors," Ylösmäki explains.

Erkko Ylosmaki | EurekAlert!
Further information:
https://www.helsinki.fi/en/news/life-science-news/new-cancer-vaccine-platform-a-potential-tool-for-tailored-and-efficacious-targeted-cancer-therapy
http://dx.doi.org/10.1016/j.ymthe.2018.06.008

More articles from Health and Medicine:

nachricht Novel technology enables detection of early-stage lung cancer when surgical cure still is possible
08.10.2018 | Elsevier

nachricht Typical mutations in children of radar soldiers
05.10.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Flying High with VCSEL Heating

Additive manufacturing processes are booming, with the rapid growth of the formnext trade fair a clear indication of this. At formnext 2018, the Fraunhofer Institute for Laser Technology ILT will be showing a new process in which the component in the powder bed is heated with laser diodes. As a result, distortion can be reduced, taller parts generated and new materials used.

In just three years, formnext has established itself as the industry meeting place to get the latest on additive manufacturing (AM) processes. With 470...

Im Focus: Breakthrough in quantum physics: Reaction of quantum fluid to photoexcitation of dissolved particles

Researchers from Graz University of Technology have described for the first time the dynamics which takes place within a trillionth of a second after photoexcitation of a single atom inside a superfluid helium nanodroplet.

In his research, Markus Koch, Associate Professor at the Institute of Experimental Physics of Graz University of Technology (TU Graz), concentrates on...

Im Focus: Chemists of TU Dresden develop highly porous material, more precious than diamonds

World Record of Cavities

Porosity is the key to high-performance materials for energy storage systems, environmental technologies or catalysts: The more porous a solid state material...

Im Focus: New function of “kidney-gene”: WT1 plays a role in the central nervous system and controls movement

The WT1 gene fulfills a central role in the development of a healthy, proper functioning kidney. Mutations in WT1 lead to impairments in kidney development and cause Wilms tumors, a pediatric kidney cancer. Researchers of the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena have now discovered a further important function of WT1. It is also active outside the kidneys in the central nervous system and is involved in controlling movement. If the gene is missing in the spinal cord, locomotor aberrancies occur. The results have now been published in Life Science Alliance.

Transcription factor WT1 (Wilms tumor 1) has been known for nearly 30 years and it is significantly involved in the development of a healthy and properly...

Im Focus: Master of the tree – novel form of dendritic inhibition discovered

A unique feature that sets neurons apart from all other cells are their beautiful, highly elaborate dendritic trees. These structures have evolved to receive the vast majority of information entering a neuron, which is integrated and processed by virtue of the dendrites’ geometry and active properties. Higher brain functions such as memory and attention all critically rely on dendritic computations, which are in turn controlled by inhibitory synaptic input. A team of scientists, led by Johannes J. Letzkus (MPI for Brain Research), now has identified a novel form of inhibition that dominantly controls dendritic function and strongly depends on previous experiences.

Our brain is a remarkably complex system. It is not only comprised of billions of neurons, but each individual neuron by itself even has exceptional processing...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

5th International Conference on Cellular Materials (CellMAT), Scientific Programme online

02.10.2018 | Event News

Major Project: The New Silk Road

01.10.2018 | Event News

"Boston calling": TU Berlin and the Weizenbaum Institute organize a conference in USA

21.09.2018 | Event News

 
Latest News

Novel technology enables detection of early-stage lung cancer when surgical cure still is possible

08.10.2018 | Health and Medicine

Larger cities have smaller water footprint than less populated counterparts

08.10.2018 | Power and Electrical Engineering

Quadruple Excellence

08.10.2018 | Awards Funding

VideoLinks
Science & Research
Overview of more VideoLinks >>>